Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT138812013376N1Phase 3Completed
Phase 3 trial of magnesium sulfate (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoint: Change in intraocular pressure due to general anesthesia. Started Jul 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT138812013376N1.